WFA
GSK icon

West Financial Advisors’s GSK GSK Stock Holding History

West Financial Advisors’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-35
Closed -$1.72K – 213
2025
Q4 		$1.72K Buy
+35
New +$1.63K ﹤0.01% 204
2022
Q2 		– Sell
-31
Closed -$2K – 176
2022
Q1 		$2K Buy
+31
New +$1.68K ﹤0.01% 176

Other funds holding GSK

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
JEST
JTC Employer Solutions Trustee St Helier, Jersey $1.2B AUM 37.55% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

West Financial Advisors's GSK Position: Q1 2026 in Review

West Financial Advisors sold out of GSK (GSK) in Q1 2026, closing a stake of 35 shares — an estimated $1.72K sold.

West Financial Advisors first reported a position in GSK in Q1 2022 and held it in 2 quarters. The position peaked at $2K in Q1 2022. 1,031 funds tracked by Wall St. Rank hold GSK as of Q1 2026.

  • West Financial Advisors reported no remaining GSK position as of Q1 2026 after selling out during the quarter.
  • West Financial Advisors sold 35 GSK shares in Q1 2026, an estimated $1.72K.
  • West Financial Advisors first reported a position in GSK in Q1 2022 and held it in 2 quarters.
  • West Financial Advisors's GSK position peaked at $2K in Q1 2022.
  • 1,031 funds tracked by Wall St. Rank held GSK as of Q1 2026.

Based on West Financial Advisors's 13F filing for Q1 2026, filed 8 Apr 2026.